Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Necitumumab + mFOLFOX-6 in Metastatic Colorectal Cancer
NCT00835185Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2007
- Primary completion
- Jan 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of necitumumab in colorectal cancer (CRC), sponsored by Eli Lilly and Company. Started Aug 2007; status: completed.
02
Drugs
necitumumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00835185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00835185.